Status:
UNKNOWN
Pharmacokinetic of Ceftriaxone in Septic ICU Patients
Lead Sponsor:
Association Pour La Promotion A Tours De La Reanimation Medicale
Conditions:
Sepsis
Severe Sepsis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Ceftriaxone pharmacokinetics variability in intensive care unit septic patients In intensive care units, drug dosage is often based on study made on healthy volunteers or on less severe patients. Ho...
Detailed Description
This is a one centre population pharmacokinetics non interventional study. One group of 50 patients allows the development of the model and a second group of 20 patients will be used for the validatio...
Eligibility Criteria
Inclusion
- Eighteen-year or more
- sepsis, severe sepsis or septic shock (according to Bone's criteria)
- admission to intensive care unit
- informed consent obtained
- affiliation to medicare
Exclusion
- Previous haemodialysis
- hemopathy
- known allergy to cephalosporin
- patients whose death is considered imminent
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00449800
Start Date
July 1 2006
End Date
March 1 2007
Last Update
March 21 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cenrte Hospitalier Régional Universitaire
Tours, France, 37044